Company intelligence / Profile preview

Kairos Ventures

Beverly Hills, California, United Stateslinkedin.com ↗

Ownership: Private
Employees: ~57
Development stage: Phase 2

Overview

Kairos Ventures is an active venture capital firm investing in early-stage life science and deep tech startups. Its biotech/pharma investments include clinical-stage programs in oncology and regenerative medicine through its portfolio companies. The firm provides both capital ($150K–$20M) and strategic support to help commercialize scientific discoveries from top universities.

Therapeutic areas: NephrologyImmunologyOtherOncologyNeurology
Modalities: Small moleculeMonoclonal antibodyCell therapyGene therapyDeviceBiologicPlatform technology
Industry: Investors

Drug pipeline

1 asset

elraglusib

Phase 2

Indications: Pancreatic ductal adenocarcinoma

Partnerships

Kairos Ventures collaborates closely with leading academic institutions for deal sourcing but does not list specific pharma partnerships as a VC. Portfolio companies may have their own partnerships.

Beyond the preview

Go deeper on Kairos Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kairos Ventures.

Explore the full profile